These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 1975146)

  • 1. [Treatment of drug-resistant depression by intravenous administration of antidepressants].
    Kielholz P
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1990; 90(4):53-6. PubMed ID: 1975146
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Treatment of depression with intravenous infusions of clomipramine and maprotiline].
    Bogdanowicz E; Kalinowski A; Swiecicki L
    Psychiatr Pol; 1991; 25(3-4):19-24. PubMed ID: 1821972
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Treatment of therapy-resistant depressions. Results of combined infusion treatment].
    Kielholz P; Terzani S; Gastpar M; Adams C
    Schweiz Med Wochenschr; 1982 Aug; 112(31-32):1090-5. PubMed ID: 7134934
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Infusion therapy with antidepressants in patients with depression].
    Haenel T
    Schweiz Rundsch Med Prax; 1993 Feb; 82(8):213-6. PubMed ID: 8441876
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of oral and intravenous treatment of depressive states: preliminary results of a WHO collaborative study.
    Gastpar M; Ngo Khac T; Gilsdorf U; Baumann P
    Clin Neuropharmacol; 1986; 9 Suppl 4():434-6. PubMed ID: 3552218
    [No Abstract]   [Full Text] [Related]  

  • 6. [Management of treatment-resistant depression without ECT (author's transl)].
    Kielholz P; Terzani S; Gastpar M; Adams C
    Dtsch Med Wochenschr; 1981 May; 106(21):671-3. PubMed ID: 6113126
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical experience with maprotilin and maprotilin/clomipramine infusions in resistant depression.
    Zapletálek M; Zbytovský J; Kudrnová K
    Act Nerv Super (Praha); 1982 May; 24(2):73-6. PubMed ID: 7102227
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Management of treatment-resistant depression (author's transl)].
    Kielholz P; Terzani S; Gastpar M
    Dtsch Med Wochenschr; 1978 Feb; 103(6):241-3. PubMed ID: 627181
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Current treatment of depression].
    Kielholz P
    Ther Umsch; 1983 Sep; 40(9):788-96. PubMed ID: 6138874
    [No Abstract]   [Full Text] [Related]  

  • 10. Intravenous maprotiline in severe and resistant primary depression: a double-blind comparison with clomipramine.
    Drago F; Motta A; Grossi E
    J Int Med Res; 1983; 11(2):78-84. PubMed ID: 6343154
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Controlled trial on the possible advantages of a combined therapy with maprotiline and haloperidol in endogenous depression.
    Möller HJ; Kissling W; Herberger B; Binz U; Wendt G; Spahn H
    Pharmacopsychiatry; 1986 Sep; 19(5):362-4. PubMed ID: 3534899
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Treatment of endogenous depressions with maprotiline, clomipramine, dibenzepine and pyrlindole (author's transl)].
    Zapletálek M; Zbytovský J; Libiger J; Pazdírek S; Cápová E
    Cesk Psychiatr; 1981 Jun; 77(3):198-203. PubMed ID: 6119162
    [No Abstract]   [Full Text] [Related]  

  • 13. Severe depression treatment: experience using maprotiline (Ludiomil) in combination with clomipramine (Anafranil).
    Ovuga E
    East Afr Med J; 1985 Feb; 62(2):79-81. PubMed ID: 4042927
    [No Abstract]   [Full Text] [Related]  

  • 14. Maprotiline in adult depressed patients. A study of the relation between clinical efficacy and serum concentrations after repeated intravenous and peroral administration.
    Fischbach R
    Arzneimittelforschung; 1979; 29(2):352-5. PubMed ID: 36112
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biological predictors of success of antidepressant drug therapy.
    Fähndrich E
    Psychiatr Dev; 1987; 5(2):151-71. PubMed ID: 3628243
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparison of high and low dosage regimes of maprotiline (Ludiomil).
    Donald JF
    J Int Med Res; 1977; 5 Suppl 4():3-10. PubMed ID: 338400
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The treatment of Depression comparing divided and single doses of maprotiline (Ludiomil).
    Waxman D
    J Int Med Res; 1977; 5 Suppl 4():11-21. PubMed ID: 590606
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Are there distinct biochemical subtypes of depression? EEG characteristics of clinically defined on-drug responders and non-responders.
    Ulrich G; Haug HJ; Stieglitz RD; Fähndrich E
    J Affect Disord; 1988; 15(2):181-5. PubMed ID: 2975689
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Noveril treatment of patients with treatment-resistant depressions (comparative evaluation of technics of intravenous drip administration)].
    Panteleeva GP; Borisova KE; Mikhaĭlova NM
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1984; 84(8):1221-6. PubMed ID: 6149662
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Infusion treatment of depressive conditious using Ludiomil].
    Dorninger F; Eichberger G; Steiner S
    Wien Med Wochenschr; 1976 Nov; 126(47):667-71. PubMed ID: 793202
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.